Skip to main content

Multidisciplinary Rehabilitation Following Upper Gastrointestinal Cancer Surgery (RESTORE II): A Definitive Randomized Controlled Trial

In brief

Multidisciplinary rehab boosts VO2peak by about 1.5 mL/kg/min after 12 weeks

In a definitive trial of 88 disease-free upper gastrointestinal cancer survivors, a 12-week program of supervised aerobic and resistance exercise, nutrition counseling, and psychosocial support raised cardiorespiratory fitness by roughly 1.5 mL/min/kg compared with standard care, an effect that persisted three months later. Other measures such as muscle strength, body composition and quality of life did not differ, leaving the broader functional impact uncertain.

Journal
Annals of surgery (Q1)
Published
2 September 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Linda M O'Neill, Emily Smyth, Neil Kearney, Grainne Sheill, Louise Brennan, Sophie Grehan, et al.
PMID
42681576
DOI
10.1097/SLA.0000000000007189

Why clinicians should know about it

  • Picked for Rehabilitation (top studies of the week, 22 November 2026): RCT of multidisciplinary rehab after upper GI cancer surgery

Abstract

OBJECTIVE: RESTORE II compared in an RCT the impact of a 12-week multidisciplinary rehabilitation program versus standard care (SC) on cardiorespiratory fitness and physical function in patients postupper gastrointestinal (UGI) oncologic surgery. SUMMARY OF BACKGROUND DATA: The value of multidisciplinary cancer rehabilitation in UGI cancer survivorship is unclear, with limited high-quality data. METHODS: Disease-free patients, ≥3 months post-UGI cancer resection were randomized to SC or RESTORE (physiotherapy-led aerobic and resistance exercise, dietary counselling, and psychosocial support). The primary endpoint was cardiorespiratory fitness (VO2peak). Secondary endpoints included body composition (anthropometry and bioimpedance analysis), muscle strength (hand grip strength and leg-press 1-repetition maximum), functional performance (Short Physical Performance Battery), physical activity (accelerometery), and health-related quality of life (EORTC-QLQ-C30). Assessments were conducted at baseline (T0), postintervention (T1), and 3-month follow-up (T2). RESULTS: Eighty-eight participants were randomized to SC (n=44) or RESTORE (n=44). Median age was 67.5 (range: 43-86) years, n=60 (68.2%) male, and median time postsurgery was 33 (range: 3.5-145) months. VO₂peak remained stable in the SC group. Estimated interaction effects for time×group indicate that the mean increases in VO₂peak were greater for RESTORE relative to SC from baseline to T1, by a mean of 1.5 mL/min/kg (95% CI: 0.52-2.48; P-value=0.003), and from baseline to T2 by a mean of 1.23 mL/min/kg (95% CI: 0.18-2.27; P-value=0.02). Secondary endpoints remained stable across treatment arms with no significant differences observed. CONCLUSION: RESTORE II provides Level I evidence that cardiorespiratory fitness can be targeted and improved in survivors of UGI cancer surgery.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.